Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

The HPV infection in males: an update.

Giraldi G, De Luca d'Alessandro E.

Ann Ig. 2012 Nov-Dec;24(6):497-506.

PMID:
23234187
2.

[The disease burden of human papillomavirus in men is substantial and can potentially be prevented].

Kiellberg Larsen H, Kofoed K, Sand C.

Ugeskr Laeger. 2013 Feb 4;175(6):349-53. Review. Danish.

PMID:
23402241
3.

Estimating the clinical benefits of vaccinating boys and girls against HPV-related diseases in Europe.

Marty R, Roze S, Bresse X, Largeron N, Smith-Palmer J.

BMC Cancer. 2013 Jan 8;13:10. doi: 10.1186/1471-2407-13-10.

4.

Cancers attributable to human papillomavirus infection.

Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.

Sex Health. 2010 Sep;7(3):244-52. doi: 10.1071/SH10020.

PMID:
20719211
5.

Beyond cervical cancer: burden of other HPV-related cancers among men and women.

Chaturvedi AK.

J Adolesc Health. 2010 Apr;46(4 Suppl):S20-6. doi: 10.1016/j.jadohealth.2010.01.016.

PMID:
20307840
6.

Global burden of human papillomavirus and related diseases.

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S.

Vaccine. 2012 Nov 20;30 Suppl 5:F12-23. doi: 10.1016/j.vaccine.2012.07.055. Review.

PMID:
23199955
7.

A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.

Goldstone SE, Vuocolo S.

Expert Rev Vaccines. 2012 Apr;11(4):395-406. doi: 10.1586/erv.12.20. Review.

PMID:
22551023
8.

Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review.

Hartwig S, Syrjänen S, Dominiak-Felden G, Brotons M, Castellsagué X.

BMC Cancer. 2012 Jan 20;12:30. doi: 10.1186/1471-2407-12-30. Review.

9.

Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1705-8.

10.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Dec 29;31 Suppl 5:F1-31. doi: 10.1016/j.vaccine.2013.10.001. Review.

PMID:
24331745
11.

Provinces weighing HPV vaccination of boys.

Eggertson L.

CMAJ. 2012 Mar 20;184(5):E250-1. doi: 10.1503/cmaj.109-4140. Epub 2012 Feb 27. No abstract available.

12.

Global prevention and management of human papillomavirus related diseases: the pressing challenges and the compelling opportunities. Foreword.

Broker TR.

Vaccine. 2012 Nov 20;30 Suppl 5:vii-x. doi: 10.1016/j.vaccine.2012.07.071. No abstract available.

PMID:
23199970
13.

Should my son get an HPV vaccine?

Stabb JE, Buckley R.

JAAPA. 2011 Jan;24(1):53. No abstract available.

PMID:
21261150
14.

[The human papillomavirus vaccine: is it of value in dermatology?].

Pedragosa-Jové R, Salleras-Redonet M; Miembros fundadores del Grupo de trabajo de Epidemiología y Prevención de la Salud en Dermatología.

Actas Dermosifiliogr. 2012 Mar;103(2):92-3. doi: 10.1016/j.ad.2011.11.007. Epub 2012 Jan 30. Spanish. No abstract available.

PMID:
22296714
15.

Comprehensive control of human papillomavirus infections and related diseases.

Bosch FX, Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJ, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, de Sanjosé S; Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5, 2012.

Vaccine. 2013 Nov 22;31 Suppl 8:I1-31. doi: 10.1016/j.vaccine.2013.07.026. Review.

16.

HPV vaccination in boys and men.

Stanley M.

Hum Vaccin Immunother. 2014;10(7):2109-11. doi: 10.4161/hv.29137. Review.

17.

Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.

Broomall EM, Reynolds SM, Jacobson RM.

Postgrad Med. 2010 Mar;122(2):121-9. doi: 10.3810/pgm.2010.03.2129. Review.

PMID:
20203463
18.

Prophylactic human papillomavirus vaccines: past, present and future.

Anderson LA.

Pathology. 2012 Jan;44(1):1-6. doi: 10.1097/PAT.0b013e32834d7bd8. Review.

PMID:
22157686
19.

Acceptability of HPV vaccines and perceptions related to genital warts and penile/anal cancers among men who have sex with men in Hong Kong.

Wang Z, Mo PK, Lau JT, Lau M, Lai CH.

Vaccine. 2013 Sep 23;31(41):4675-81. doi: 10.1016/j.vaccine.2013.06.090. Epub 2013 Jul 8.

PMID:
23845815
20.

Impact of prophylactic human papillomavirus vaccines on dermatology and venereology.

Gross G.

G Ital Dermatol Venereol. 2008 Aug;143(4):259-65. Review.

PMID:
18833082

Supplemental Content

Support Center